Science, Startup, Tech, Venture Capital, News.
approach to drug discovery makes sense intuitively; it just wasn’t feasible until now. With over thirty drug candidates across more than twenty diseases, it’s safe to say the technology is working. But wait, there’s more. The two million new images and twenty terabytes of data that Recursion